These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14718160)

  • 21. Antifungal activity of chalcones: a mechanistic study using various yeast strains.
    Lahtchev KL; Batovska DI; Parushev SP; Ubiyvovk VM; Sibirny AA
    Eur J Med Chem; 2008 Oct; 43(10):2220-8. PubMed ID: 18280009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Target site occupancy: emerging generalizations from clinical and preclinical studies.
    Grimwood S; Hartig PR
    Pharmacol Ther; 2009 Jun; 122(3):281-301. PubMed ID: 19306894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and genomic approaches to identify and study the targets of bioactive small molecules.
    Zheng XS; Chan TF; Zhou HH
    Chem Biol; 2004 May; 11(5):609-18. PubMed ID: 15157872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced apoptosis in yeast.
    Almeida B; Silva A; Mesquita A; Sampaio-Marques B; Rodrigues F; Ludovico P
    Biochim Biophys Acta; 2008 Jul; 1783(7):1436-48. PubMed ID: 18252203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An integrated platform of genomic assays reveals small-molecule bioactivities.
    Hoon S; Smith AM; Wallace IM; Suresh S; Miranda M; Fung E; Proctor M; Shokat KM; Zhang C; Davis RW; Giaever G; St Onge RP; Nislow C
    Nat Chem Biol; 2008 Aug; 4(8):498-506. PubMed ID: 18622389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. QTL mapping by pooled-segregant whole-genome sequencing in yeast.
    Pais TM; Foulquié-Moreno MR; Thevelein JM
    Methods Mol Biol; 2014; 1152():251-66. PubMed ID: 24744038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replicated, replicable and relevant-target engagement and pharmacological experimentation in the 21st century.
    Kenakin T; Bylund DB; Toews ML; Mullane K; Winquist RJ; Williams M
    Biochem Pharmacol; 2014 Jan; 87(1):64-77. PubMed ID: 24269285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The state-of-the-art in predictive toxicogenomics.
    Fielden MR; Kolaja KL
    Curr Opin Drug Discov Devel; 2006 Jan; 9(1):84-91. PubMed ID: 16445120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Yeast genome sequencing: the power of comparative genomics.
    Piskur J; Langkjaer RB
    Mol Microbiol; 2004 Jul; 53(2):381-9. PubMed ID: 15228521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How is gene-expression profiling going to challenge the future management of lung cancer?
    Santos ES; Perez CA; Raez LE
    Future Oncol; 2009 Aug; 5(6):827-35. PubMed ID: 19663732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A network solution.
    Henney A; Superti-Furga G
    Nature; 2008 Oct; 455(7214):730-1. PubMed ID: 18843342
    [No Abstract]   [Full Text] [Related]  

  • 32. Transcriptome analysis of Paracoccidioides brasiliensis cells undergoing mycelium-to-yeast transition.
    Nunes LR; Costa de Oliveira R; Leite DB; da Silva VS; dos Reis Marques E; da Silva Ferreira ME; Ribeiro DC; de Souza Bernardes LA; Goldman MH; Puccia R; Travassos LR; Batista WL; Nóbrega MP; Nobrega FG; Yang DY; de Bragança Pereira CA; Goldman GH
    Eukaryot Cell; 2005 Dec; 4(12):2115-28. PubMed ID: 16339729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional annotation of chemical libraries across diverse biological processes.
    Piotrowski JS; Li SC; Deshpande R; Simpkins SW; Nelson J; Yashiroda Y; Barber JM; Safizadeh H; Wilson E; Okada H; Gebre AA; Kubo K; Torres NP; LeBlanc MA; Andrusiak K; Okamoto R; Yoshimura M; DeRango-Adem E; van Leeuwen J; Shirahige K; Baryshnikova A; Brown GW; Hirano H; Costanzo M; Andrews B; Ohya Y; Osada H; Yoshida M; Myers CL; Boone C
    Nat Chem Biol; 2017 Sep; 13(9):982-993. PubMed ID: 28759014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The application of RAGE and GECKO in cell-based target discovery screens.
    Brunden K; Sherf B; Harrington J
    Pharmacogenomics; 2005 Jun; 6(4):383-92. PubMed ID: 16004556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic genome engineering forging new frontiers for wine yeast.
    Pretorius IS
    Crit Rev Biotechnol; 2017 Feb; 37(1):112-136. PubMed ID: 27535766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.
    Outeiro TF; Giorgini F
    Biotechnol J; 2006 Mar; 1(3):258-69. PubMed ID: 16897706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide drug-induced haploinsufficient screening of fission yeast for identification of hydrazinocurcumin targets.
    Baek ST; Kim DU; Han S; Woo IS; Nam M; Kim L; Heo KS; Lee H; Hwang HR; Choi SJ; Won M; Lee M; Park SK; Lee S; Kwon HJ; Maeng PJ; Park HM; Park Y; Kim D; Hoe KL
    J Microbiol Biotechnol; 2008 Feb; 18(2):263-9. PubMed ID: 18309270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NIMH Preclinical/Clinical Therapeutics Research meeting--preclinical drug discovery session.
    Douglas SD
    J Neuroimmune Pharmacol; 2007 Mar; 2(1):5-7. PubMed ID: 18040819
    [No Abstract]   [Full Text] [Related]  

  • 39. Changing perspectives in yeast research nearly a decade after the genome sequence.
    Dolinski K; Botstein D
    Genome Res; 2005 Dec; 15(12):1611-9. PubMed ID: 16339358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. yMGV: helping biologists with yeast microarray data mining.
    Le Crom S; Devaux F; Jacq C; Marc P
    Nucleic Acids Res; 2002 Jan; 30(1):76-9. PubMed ID: 11752259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.